Assistant Professor, Urology, UCLA School of Medicine
Urology
Dr. Karim Chamie, MD
|
|
Give Review
Karim Chamie works in the field of Urology. He studied medicine at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31 in research and 72 in primary care medicine He has 2 awards "Research Career Development Award" and "SEED Grant". Karim Chamie is a published doctor as well. He has 51 publications published. The latest was: Population-based assessment of determining predictors for quality of prostate cancer surveillance. Karim Chamie, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Population-based assessment of determining predictors for quality of prostate Cancer surveillance.
- Population-Based Assessment of Determining Treatments for Prostate Cancer.
- Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC).
- Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply.
- Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic Renal cell carcinoma: Data from the phase III ARISE...
- Population-based assessment of prostate-specific antigen testing for prostate Cancer in the elderly.
- The future of Bladder cancer care in the USA.
- Quality of diagnostic staging in patients with Bladder cancer: a process-outcomes link.
- Bladder cancer in 2014: From the genomic frontier to immunotherapeutics.
- Treatment and survival in patients with recurrent high-risk non-muscle-invasive Bladder cancer.
- Comparative effectiveness of robot-assisted versus open radical prostatectomy Cancer control.
- The role of magnetic resonance imaging in delineating clinically significant prostate Cancer.
- Building a Medical Neighborhood in the Safety Net: An Innovative Technology Improves Hematuria Workups.
- Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate Cancer.
- Recurrence of high-risk Bladder cancer: A population-based analysis.
- Body Mass Index and Prostate Cancer Severity: Do Obese Men Harbor More Aggressive Disease on Prostate Biopsy?
- Deletions of chromosomes 3p and 14q molecularly subclassify clear cell Renal cell carcinoma.
- Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery.
- Comorbidity and competing risks for mortality in men with prostate Cancer.
- Histopathology of surgically treated Renal cell carcinoma: survival differences by subtype and stage.
- Comorbidities, Treatment and Survival.
- Comorbidities, treatment and ensuing survival in men with prostate Cancer.
- Impact of a Bladder Cancer Diagnosis on Smoking Behavior.
- The impact of social networks and partnership status on treatment choice in men with localized prostate Cancer.
- Quality of care in patients with Bladder cancer: a case report?
- Systemic therapy for metastatic Renal cell carcinoma: a review and update.
- Prostate Cancer survivorship: lessons from caring for the uninsured.
- Quality of Bladder cancer care in the USA.
- Improved prediction of long-term, other cause mortality in men with prostate Cancer.
- The role of self-efficacy in quality of life for disadvantaged men with prostate Cancer.
- Compliance with guidelines for patients with Bladder cancer: variation in the delivery of care.
- Patients and solipsism: the psychology of decision making for prostate Cancer treatment.
- Effect of Age on Transitional Cell Carcinoma of the Upper Urinary Tract: Presentation, Treatment, and Outcomes.
- Overtreatment of men with low-risk prostate Cancer and significant comorbidity.
- Outcomes after pediatric Ureteral reimplantation: a population based analysis.
- Bone scan overuse in staging of prostate Cancer: an analysis of a Veterans Affairs cohort.
- Secondary malignancies among nonseminomatous germ cell tumor Cancer survivors.
- Physician assessment of pretreatment functional status: a process-outcomes link.
- Prostate Cancer: the challenge of comparing open and laparoscopic surgery.
- Contemporary open Ureteral reimplantation without morphine: assessment of pain and outcomes.
- Nuclear versus cytoplasmic localization of filamin A in prostate Cancer: immunohistochemical correlation with metastases.
- Sociodemographic factors associated with nephrectomy in patients with metastatic Renal cell carcinoma.
- The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate Cancer.
- Agent Orange exposure, Vietnam War veterans, and the risk of prostate Cancer.
- Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?
- Short stay pyeloplasty: variables affecting pain and length of stay.
- Cost-benefit and outcome analysis: effect of Prostate biopsy undergrading.
- Benign retroperitoneal schwannoma: a case series and review of the literature.
- Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity.
- Enhancing insulin action: from chemical elements to thiazolidinediones.
Schools
University of Southern California Keck School of Medicine
Procedures Preformed
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Lithotripsy
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Research Career Development Award
- SEED Grant
Education
-
UCLA Medical Center -
UCLA School of Public Health -
University of California Davis -
Keck School of Medicine of USC
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1962478420 | |
| NPPES Provider LastName | CHAMIE | |
| NPPES Provider FirstName | KARIM | |
| NPPES Provider ZIPCode | 904041135 | |
| NPPES Provider State | CA | |
| Specialty Description | Urology | |
| Total Claim Count | 418.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 38.0 | |
| Percent Opioid Claims | 9.09 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962478420 |
| Last Name Of The Provider | CHAMIE |
| First Name Of The Provider | KARIM |
| View All |
Similar Doctors
|
Dr. Premal J. Desai, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Philip E. Werthman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Ehrlich, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arnold C. Cinman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonard S. Marks, MD |
|
|
Dr. Isla P. Garraway, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew J. Hung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mehran Movassaghi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Lassoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy D. McClure, MD |
|
|
Dr. Patrick M. Ramos, MD |
|
|
Dr. Sevan V. Stepanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Vainrib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin J. Yuh, MD |